| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.21 | 1e-06 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.092 | 0.06 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.082 | 0.08 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.05 | 0.3 |